tirzepatide no longer shortage FDA reconsidering its decision to take off its drug list Mounjaro and Zepbound Are No

Information last revised July 2022

For long-term use beyond 68 weeks, ongoing studies are examining 3+ year safety and effect, preliminary data suggests kept safety with extended use, and no new safety concerns have emerged in available long-term data

doi: 10.2337/dc13-2759 [DOI] [PubMed] [Google Scholar] 14.Luo J, Feldman R, Rothenberger S, Korytkowski M, Fischer MA, Gellad WF

Activates GLP-1 receptors only

Many commercial plans exclude weight loss medications entirely or cover them only for patients with BMI 30 kg/m or BMI 27 kg/m with weight-related comorbidities

In contrast, selective depletion of mtGSH initiates a defined cascade of pro-apoptotic events